Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 1
1995 1
2002 3
2003 3
2004 5
2005 12
2006 12
2007 11
2008 10
2009 9
2010 7
2011 6
2012 7
2013 20
2014 10
2015 8
2016 9
2017 15
2018 9
2019 10
2020 13
2021 24
2022 29
2023 15
2024 16
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA; DESTINY-Breast03 Trial Investigators. Cortés J, et al. N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Pfob A, Cai L, Schneeweiss A, Rauch G, Thomas B, Schaefgen B, Kuemmel S, Reimer T, Hahn M, Thill M, Blohmer JU, Hackmann J, Malter W, Bekes I, Friedrichs K, Wojcinski S, Joos S, Paepke S, Degenhardt T, Rom J, Rody A, van Mackelenbergh M, Banys-Paluchowski M, Große R, Reinisch M, Karsten MM, Sidey-Gibbons C, Wallwiener M, Golatta M, Heil J. Pfob A, et al. Among authors: rody a. Ann Surg Oncol. 2024 Feb;31(2):957-965. doi: 10.1245/s10434-023-14551-8. Epub 2023 Nov 10. Ann Surg Oncol. 2024. PMID: 37947974 Free PMC article.
Primary ovarian leiomyoma: a rare ovarian tumour.
Pervan M, Gembicki M, Princk H, Rody A, Hanker L, Hemptenmacher F, Banys-Paluchowski M. Pervan M, et al. Among authors: rody a. Arch Gynecol Obstet. 2023 Oct;308(4):1379-1380. doi: 10.1007/s00404-022-06842-4. Epub 2022 Dec 21. Arch Gynecol Obstet. 2023. PMID: 36539622 Free PMC article.
Latissimus dorsi flap for breast reconstruction: a large single-institution evaluation of surgical outcome and complications.
Banys-Paluchowski M, Brus L, Krawczyk N, Kopperschmidt SV, Gasparri ML, Bündgen N, Rody A, Hanker L, Hemptenmacher F, Paluchowski P. Banys-Paluchowski M, et al. Among authors: rody a. Arch Gynecol Obstet. 2024 Jan;309(1):269-280. doi: 10.1007/s00404-023-07186-3. Epub 2023 Aug 16. Arch Gynecol Obstet. 2024. PMID: 37584773 Free PMC article.
HER2-Positive Early Breast Cancer: Time for Ultimate De-Escalation?
Tauber N, Cirkel C, Claussen A, Fick F, Kontomanolis E, Krawczyk N, Rody A, Banys-Paluchowski M. Tauber N, et al. Among authors: rody a. Cancers (Basel). 2024 Mar 11;16(6):1121. doi: 10.3390/cancers16061121. Cancers (Basel). 2024. PMID: 38539456 Free PMC article. Review.
234 results